Eslicarbazepine Acetate as Adjunctive Therapy for Primary Generalized Tonic-Clonic Seizures in Adults: A Prospective Observational Study

BACKGROUND: Eslicarbazepine acetate (ESL), a novel sodium channel blocker, is approved for mono and adjunctive treatment of partial epileptic seizures with or without secondary generalization. Its efficacy in primary generalized seizures has not yet been evaluated. OBJECTIVE: To evaluate the efficac...

Descripción completa

Detalles Bibliográficos
Autores principales: Winter, Yaroslav, Sandner, Katharina, Vieth, Thomas Ludger, Melzer, Nico, Klimpe, Sven, Meuth, Sven G., Groppa, Sergiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550753/
https://www.ncbi.nlm.nih.gov/pubmed/36178588
http://dx.doi.org/10.1007/s40263-022-00954-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550753/
https://www.ncbi.nlm.nih.gov/pubmed/36178588
http://dx.doi.org/10.1007/s40263-022-00954-w

Ejemplares similares